Pharmacy World & Science

, Volume 31, Issue 2, pp 241–245 | Cite as

Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences

  • P. Ravi ShankarEmail author
  • Baburam Humagain
  • R. M. Piryani
  • Nisha Jha
  • Bidur Osti


Drug and Therapeutics Committees (DTCs) serve as a forum to bring together various stakeholders to improve drug use. DTCs are a key intervention to promote rational use of medicines. DTCs are however, functioning in only a limited number of hospitals in Nepal. A Medicine and Therapeutics Committee (MTC) was started at KIST Medical College, a new medical school in Lalitpur district, Nepal to promote the rational use of medicines in February 2008. The MTC has members from various departments and the full support of the administration. The MTC has been involved in preparing the hospital medicine list and limiting the number of brands available in the pharmacy. Measures to regulate pharmaceutical promotion have been undertaken. Pharmacovigilance and medication counseling activities have been started. Educational programs for various levels of staff are regularly carried out and drug use in the hospital is periodically monitored. Initial experiences regarding MTC functioning is positive.


Medicines Nepal Drug and Therapeutics Committee Rational use of medicines 


  1. 1.
    Holloway K, Green T. Drug and Therapeutics Committees—A practical guide. Geneva: World Health organization; 2003.Google Scholar
  2. 2.
    Weekes LM, Brooks C. Drugs and Therapeutic Committees in Australia: expected and actual performance. Br J Clin Pharmacol. 1996;42:551–7.PubMedGoogle Scholar
  3. 3.
    Thurmann PA, Harder S, Steioff A. Structure and activities of hospital drug committees in Germany. Eur J Clin Pharmacol. 1997;52:429–35. doi: 10.1007/s002280050315.PubMedCrossRefGoogle Scholar
  4. 4.
    Björkman IK, Schmidt IK, Holmström I, Bernsten CB. Developing the role of the drug and therapeutics committees: perceptions of chairs. Int J Health Care Qual Assur. 2007;20:161–78. doi: 10.1108/09526860710731843.PubMedCrossRefGoogle Scholar
  5. 5.
    Laing R, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve the use of medicines in developing countries. Health Policy Plan. 2001;16:13–20. doi: 10.1093/heapol/16.1.13.PubMedCrossRefGoogle Scholar
  6. 6.
    Mishra P, Alurkar VM, Subish P. Functions of a drug and therapeutics committee in Nepal. J Pharm Pract Res. 2006;36:81.Google Scholar
  7. 7.
    Palaian S, Mishra P. Role of drug and therapeutics committee towards drug safety-experiences from western Nepal. Kathmandu Univ Med J. 2005;3:79–80.Google Scholar
  8. 8.
    Palaian S, Mishra P, Shankar PR, Bista D, Purwar B. Contribution of the regional drug information center towards drug safety. JNMA J Nepal Med Assoc. 2006;45:216–8.PubMedGoogle Scholar
  9. 9.
    Dartnell J. Activities to improve hospital prescribing. Aust Prescr. 2001;24:29–31.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • P. Ravi Shankar
    • 1
    Email author
  • Baburam Humagain
    • 2
  • R. M. Piryani
    • 3
  • Nisha Jha
    • 4
  • Bidur Osti
    • 5
  1. 1.Department of Clinical PharmacologyKIST Medical CollegeKathmanduNepal
  2. 2.KIST Medical CollegeImadol, LalitpurNepal
  3. 3.Department of MedicineKIST Medical CollegeImadol, LalitpurNepal
  4. 4.Department of Clinical PharmacologyKIST Medical CollegeImadol, LalitpurNepal
  5. 5.KIST Medical CollegeImadol, LalitpurNepal

Personalised recommendations